Event

Advanced Biomanufacturing for Medicines: A Joint Webinar with NAE and NIIMBL

-
Bioengineering, Biomanufacturing, Biopharmaceutical, Event

Webinar
United States

Join NIIMBL for a webinar series highlighting insights from the Summer 2025 special edition of The National Academy of Engineering's (NAE) publication, The Bridge focused on Advanced Biomanufacturing for Medicines. Across two webinars hosted jointly by NAE and NIIMBL, featured authors from The Bridge discuss the impact of advanced biomanufacturing developments for improved access to life-saving medicines.

 

Advanced Biomanufacturing for Medicines: Innovating for the Future (Part One)
MARCH 11, 2026 | Noon - 1:15 pm ET
This webinar will examine how evolving platforms, peptides/oligos, and microbial routes are reframing manufacturing technology to deliver speed, standardization, and software-driven biology for greater national health and security. Panelists will discuss what it would take to bring penicillin and other antibiotics back at scale using modern bioprocessing and synthetic biology, and why U.S. reinvestment is critical. 
 

Advanced Biomanufacturing for Medicines: Gene Therapy and Reference Materials (Part Two)
APRIL 8, 2026 | Noon - 1:00 pm ET
Featured authors from NAE's The Bridge introduce two initiatives shaping the future of advanced biomanufacturing. The NIST Biomanufacturing Program provides high quality reference materials to support advances in development, characterization and manufacturing of protein drugs. The NIIMBL Open-Access Viral Vector Platform accelerates AAV-based gene therapy for rare diseases, offering scalable processes and a collaborative framework that streamlines innovation for life-saving medicines.